##common.pageHeaderLogo.altText##

Vol. 4 No. 2 (2024)

Ischemic Stroke Following Sclerotherapy of Varicose Veins

Clinical Medicine And Health Research Journal, Vol. 4 No. 2 (2024), 28 April 2024 , Page 884-886
https://doi.org/10.18535/cmhrj.v4i2.351

Abstract

Sclerotherapy consists of an injection of a sclerosing foam or liquid to occlude the varicose vein. This therapeutic method is recognized for its immediate effectiveness and its low complication rate. Certain neurological complications have been reported, notably ischemic stroke (CVA), which remains a very rare complication. We report the case of Mrs. FK aged 35, without any particular personal history, who presented to vascular surgery for sclerotherapy of her varicose veins. During the procedure, the patient presented a sudden onset of impaired consciousness associated with left hemiplegia with aphasia.


She was immediately transferred to medical intensive care. Brain computed tomography (CT) confirmed the diagnosis of stroke. As part of the etiological assessment, we performed a transesophageal echocardiography (TEE) on the 7th day of his hospitalization, which was in favor of a patent foramen ovale (PFO). In the literature, this complication has been reported by certain authors but it remains rare. CiVA is secondary to the presence of a PFO. It may be a gas embolism (related to the product used) in which case the stroke is early, or a cruoric embolism, in which case it occurs late. Is echocardiography systematic before sclerotherapy? Through this case and referring to the literature, we will review this entity of stroke of rare etiology.

Keywords:
  • sclerotherapy, varicose veins, PFO, stroke, systematic echocardiography, gas embolism, cruoric embolism.

How to Cite

ABDELBAKI, M. ., BENNOUI, Z. ., & TRADI, M. . (2024). Ischemic Stroke Following Sclerotherapy of Varicose Veins. Clinical Medicine And Health Research Journal, 4(2), 884–886. https://doi.org/10.18535/cmhrj.v4i2.351

Download Citation

References

  • Drake LA, Dinehart SM, Goltz RW, et al. Guidelines of care for sclerotherapy treatment of varicose and teleangiectatic leg veins. J Am Acad Dermatol 1996; 34:523–8.
  • Rabe E, Pannier-Fischer F, Gerlach H, et al. Guidelines for sclerotherapy of varicose veins. Dermatol Surg 2004; 30:687–93.
  • Hamel-Desnos C, Ouvry P, Benigni JP, et al. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomized, double-blind trial with 2 year-follow-up. 'The 3/1 Study'. Eur J Vasc Endovasc Surg 2007; 34:723–9.
  • Chen CH, Chiu CS, Yang CH. Ultrasound-guided foam sclerotherapy for treating incompetent great saphenous veins – results of 5 years of analysis and morphologic evolution study. Dermatol Surg 2012; 38:851–7.
  • Kern P, Ramelet AA, Wutschert R, Bounameaux H, Hayoz D. Single blind randomized study comparing chromated glycerin, polidocanol solution and polidocanol foam for treatment of telangiectactic leg veins. Dermatol Surg 2004; 30:367–72.
  • Guex JJ, Allaert FA, Gillet JL. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005; 31:123–8.
  • Gillet JL, Guedes JM, Guex JJ, et al. Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicenter prospective study including 1025 patients. Phlebology 2009; 24:131–8.
  • Van der Plas JPL, Lambers JC, van Wersch JW, Koehler PJ. Reversible ischaemic neurological deficit after sclerotherapy of varicose veins. Lancet 1994; 343:428–428.
  • Künzelberger B, Pieck C, Altmeyer P, Stücker M. Ophthalmic migraine with reversible scotomas after sclerotherapy with liquid 1% polidocanol. Derm Surg 2006; 32:1410–1410.
  • Parsi K. Paradoxical embolism, stroke and sclerotherapy. Phlebology 2012; 27:147–67.
  • Parsi K. Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications. Phlebology 2011; 26:140–7.
  • Morrison N, Cavezzi A, Bergan J, Partsch H. Regarding 'stroke after varicose vein foam injection sclerotherapy'. J Vasc Surg 2006; 44:224–5.
  • Passariello F. Sclerosing foam and patent foramen ovale. The final report. In: Word Congress of the International Union of Phlebology; 2007 Jun 18–20; Kyoto, Japan. Int Angiol 2007;26:87.
  • Wagdi P. Migräne und offenes Foramen Ovale: nur ein vorübergehender Hoffnungsschimmer? Kardiovasc Med 2006; 9:32–6.
  • Gillet JL, Donnet A, Lausecker M, Guedes JM, Guex JJ, Lehmann P. Pathophysiology of visual disturbances occurring after foam sclerotherapy. Phlebology 2010; 25:261–6.
  • Busch RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008; 23:189–92.
  • Harzheim M, Becher H. Klockgether: Brain infarct from a paradoxical embolism following a varices operation. Dtsch Med Wochenschr 2000; 125:794–6.
  • Caggiati A, Franceschini M. Stroke following endovenous laser treatment of varicose veins. J Vasc Surg 2010; 51:218–20.
  • Cavezzi A, Parsi K. Complications of foam sclerotherapy. Phlebology 2012; 27(Suppl 1): 46–51.
  • Sarvananthan T, Shepherd AC, Willenberg T, Davies AH. Neurological complications of sclerotherapy for varicose veins. J Vasc Surg 2012; 55:243–51
  • Parsi K. Paradoxical embolism, stroke and sclerotherapy. Phlebology 2012; 27:147–67.
  • Busch RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008; 23:189–92.
  • Belton PJ, Nanda A, Alqadri SL, et al. Paradoxical cerebral air embolism causing large vessel occlusion treated with endovascular aspiration. J Neurointervent Surg 2017;9(4):e10. https://doi.org/10.1016/j.revmed.2019.10.293
  • Abdelhamid N, Farooq S, Sarraj A. Acute ischemic stroke in a young woman with no known risk factors. WMJ 2018;117(1):42–4.
  • Forlee MV, Grouden M., Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J. Vasc. Surg. 2006; 43/162 - 4
  • Gillet JL. Neurological disorders and foam sclerotherapy: review of the literature and pathophysiology. J Mal Vasc 2014;39(2):89.
  • Bush RG, Derrick M., Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008; 23:189-92.
  • Breu FX, Guggenbichler S., Wollmann JC; Second European Consensus Meeting on Foam Sclerotherapy. Duplex ultrasound and effectiveness in foam sclerotherapy from the 2ndEuropean Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. Vasa. 2008; 37:90-5.
  • Meier B., Lock JE Contemporary management of patent foramen ovale. Traffic 2003; 107:5-9.
  • Morrison N., Cavezzi A., Bergan J., Partsch H. Letter to the editor regarding “Stroke after varicose vein foam injection sclerotherapy”. J. Vasc. Surg 2007 44/224 – 5
  • Sfmv Recommendations – V. 2013 06.
    • Article Viewed: 0 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    Cover Image

    Information